Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gregory Rushing

Thoracic Surgery (Cardiothoracic Vascular Surgery) Columbus, OH Medical Doctor

NPI 1801057203 CMS profile 263256

452 W 10Th Ave, Columbus, OH 43210

Open in the dashboard

General payments

$90,510

355 records reported · program years 2019–2025

Research payments

$5,200

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$273,802 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Gregory Rushing of Columbus, OH is reported in the CMS Open Payments database as having received $90,510 across 355 general payments and $5,200 in research payments paid to them. Separately, studies naming them as principal investigator received $273,802 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $72,064 98
2024 General $6,315 88
2023 General $7,256 85
2023 Research $5,200 1
2022 General $2,226 39
2021 General $1,129 24
2020 General $474 13
2019 General $1,047 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Rushing
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Gregory Rushing were reported at $72,064. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Gregory Rushing Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $1,047 $886 $178–$3,167 $163
2020 $474 $341 $108–$1,605 $114
2021 $1,129 $453 $125–$1,886 $132
2022 $2,226 $695 $180–$2,566 $149
2023 $7,256 $745 $205–$2,662 $160
2024 $6,315 $799 $214–$2,967 $164
2025 $72,064 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $68,896 86 payments
  2. Medtronic, Inc. $14,351 176 payments
  3. Intuitive Surgical, Inc. $2,085 8 payments
  4. Allergan Inc. $872 4 payments
  5. Bolton Medical Inc $505 3 payments
  6. Abbott Laboratories $400 4 payments
  7. Medtronic Vascular, Inc. $387 11 payments
  8. Zimmer Biomet Holdings, Inc. $386 4 payments
  9. Baxter Healthcare $365 6 payments
  10. Edwards Lifesciences Corporation $354 8 payments
  11. Other $1,909 45 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $60,875 15 payments
  2. Food and Beverage $14,432 299 payments
  3. Travel and Lodging $8,391 33 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,760 4 payments
  5. Education $1,000 1 payment
  6. Entertainment $52 3 payments
Products named General payments · program years 2019–2025
  1. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $37,215 27 payments
  2. SYNERGY ABLATION SYSTEM $30,132 33 payments
  3. Penditure $3,704 18 payments
  4. COREVALVE EVOLUT R $3,695 79 payments
  5. Cardioblate $2,080 12 payments
  6. ATRICLIP LAA EXCLUSION SYSTEM $1,979 27 payments
  7. Avalus $1,953 21 payments
  8. Da Vinci Surgical System $1,085 7 payments
  9. DAVINCI XI $1,000 1 payment
  10. EVERA MRI XT DR SURESCAN $994 7 payments
  11. Other $6,561 118 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $5,200 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

100

Median for Cardiac Surgery: 68

Drug cost

$2,826

Median for Cardiac Surgery: $445

Branded share of claims

0%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Enoxaparin Sodium Generic 25 $2,014
Amiodarone Hcl Generic 36 $577
Atorvastatin Calcium Generic 13 $176
Metoprolol Tartrate Generic 26 $59

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$113,906

Medicare's payments for the services billed

Medicare patients

224

Average age 77

Services billed

352

76 women, 148 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 62%
Heart failure 59%
Arthritis 58%
Chronic kidney disease 47%
Diabetes 43%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • E.R. Squibb & Sons, L.L.C. $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

356 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record